BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 29067731)

  • 1. A random-censoring Poisson model for underreported data.
    de Oliveira GL; Loschi RH; Assunção RM
    Stat Med; 2017 Dec; 36(30):4873-4892. PubMed ID: 29067731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harnessing the theoretical foundations of the exponential and beta-Poisson dose-response models to quantify parameter uncertainty using Markov Chain Monte Carlo.
    Schmidt PJ; Pintar KD; Fazil AM; Topp E
    Risk Anal; 2013 Sep; 33(9):1677-93. PubMed ID: 23311599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing Monte Carlo error in the Bayesian estimation of risk ratios using log-binomial regression models.
    Salmerón D; Cano JA; Chirlaque MD
    Stat Med; 2015 Aug; 34(19):2755-67. PubMed ID: 25944082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian analysis of the differences of count data.
    Karlis D; Ntzoufras I
    Stat Med; 2006 Jun; 25(11):1885-905. PubMed ID: 16252270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian hierarchical Poisson models with a hidden Markov structure for the detection of influenza epidemic outbreaks.
    Conesa D; Martínez-Beneito MA; Amorós R; López-Quílez A
    Stat Methods Med Res; 2015 Apr; 24(2):206-23. PubMed ID: 21873301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian random-effects threshold regression with application to survival data with nonproportional hazards.
    Pennell ML; Whitmore GA; Ting Lee ML
    Biostatistics; 2010 Jan; 11(1):111-26. PubMed ID: 19828558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mixed-effect model for positive responses augmented by zeros.
    Rodrigues-Motta M; Galvis Soto DM; Lachos VH; Vilca F; Baltar VT; Junior EV; Fisberg RM; Lobo Marchioni DM
    Stat Med; 2015 May; 34(10):1761-78. PubMed ID: 25682753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mechanistic nonlinear model for censored and mismeasured covariates in longitudinal models, with application in AIDS studies.
    Zhang H; Wong H; Wu L
    Stat Med; 2018 Jan; 37(1):167-178. PubMed ID: 29034494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian semiparametric intensity estimation for inhomogeneous spatial point processes.
    Yue YR; Loh JM
    Biometrics; 2011 Sep; 67(3):937-46. PubMed ID: 21175553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of censoring on learning Bayesian networks in survival modelling.
    Stajduhar I; Dalbelo-Basić B; Bogunović N
    Artif Intell Med; 2009 Nov; 47(3):199-217. PubMed ID: 19833488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing INLA and OpenBUGS for hierarchical Poisson modeling in disease mapping.
    Carroll R; Lawson AB; Faes C; Kirby RS; Aregay M; Watjou K
    Spat Spatiotemporal Epidemiol; 2015; 14-15():45-54. PubMed ID: 26530822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.
    Willems S; Schat A; van Noorden MS; Fiocco M
    Stat Methods Med Res; 2018 Feb; 27(2):323-335. PubMed ID: 26988930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of analytical methods for overdispersed counts in cluster randomized trials: sample size, degree of clustering and imbalance.
    Durán Pacheco G; Hattendorf J; Colford JM; Mäusezahl D; Smith T
    Stat Med; 2009 Oct; 28(24):2989-3011. PubMed ID: 19672840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimations of competing lifetime data from inverse Weibull distribution under adaptive progressively hybrid censored.
    Azm WSAE; Aldallal R; Aljohani HM; Nassr SG
    Math Biosci Eng; 2022 Apr; 19(6):6252-6275. PubMed ID: 35603400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Bayesian approach to adjust for diagnostic misclassification between two mortality causes in Poisson regression.
    Stamey JD; Young DM; Seaman JW
    Stat Med; 2008 Jun; 27(13):2440-52. PubMed ID: 17979218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation in Bayesian disease mapping.
    MacNab YC; Farrell PJ; Gustafson P; Wen S
    Biometrics; 2004 Dec; 60(4):865-73. PubMed ID: 15606406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification method for disease risk mapping based on discrete hidden Markov random fields.
    Charras-Garrido M; Abrial D; Goër JD; Dachian S; Peyrard N
    Biostatistics; 2012 Apr; 13(2):241-55. PubMed ID: 22133757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian random effects selection in mixed accelerated failure time model for interval-censored data.
    Harun N; Cai B
    Stat Med; 2014 Mar; 33(6):971-84. PubMed ID: 24123191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inference on cancer screening exam accuracy using population-level administrative data.
    Jiang H; Brown PE; Walter SD
    Stat Med; 2016 Jan; 35(1):130-46. PubMed ID: 26278587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Bayesian approach for analyzing zero-inflated clustered count data with dispersion.
    Choo-Wosoba H; Gaskins J; Levy S; Datta S
    Stat Med; 2018 Feb; 37(5):801-812. PubMed ID: 29108124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.